Fatal invasive pulmonary aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus terreus: A case study

Sara Abolghasemi; Atousa Hakamifard; Somayeh Sharifynia; Mihan Pourabdollah Toutkaboni; Hamed Azhdari Tehrani

doi:10.1002/ccr3.4051

Fatal invasive pulmonary aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus terreus: A case study

Clin Case Rep. 2021 Mar 16;9(4):2414-2418. doi: 10.1002/ccr3.4051. eCollection 2021 Apr.

Authors

Sara Abolghasemi¹, Atousa Hakamifard¹, Somayeh Sharifynia², Mihan Pourabdollah Toutkaboni³, Hamed Azhdari Tehrani⁴

Affiliations

¹ Infectious Diseases and Tropical Medicine Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.
² Clinical Tuberculosis and Epidemiology Research Center National Research Institute of Tuberculosis and Lung Diseases (NRITLD) Shahid Beheshti University of Medical Sciences Tehran Iran.
³ Paediatric Respiratory Diseases Research Center National Research Institute of Tuberculosis and Lung Diseases (NRITLD) Shahid Beheshti University of Medical Sciences Tehran Iran.
⁴ Department of Hematology and Medical Oncology Shahid Beheshti University of Medical Sciences Tehran Iran.

Abstract

Case reports of CAPA emerged. In most of the reports, the predominant species is Aspergillus fumigatus. Uncommon species are less reported. Due to poor clinical outcome with Aspergillus terreus, the increasing reports with this agent require attention.

Keywords: Aspergillusterreus; CAPA; COVID‐19; ICU; SARS‐CoV‐2; aspergillosis; aspergillus.

Publication types

Case Reports